Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

ABBV vs GILD

AbbVie Inc. and Gilead Sciences, Inc. compared side by side. Customize this comparison

Performance (normalized)

-16%+20%+56%+92%+128%stockmarketcap.io

Key metrics

MetricABBV logoABBVGILD logoGILD
Price$261.07$131.27
Market cap$461.26B$162.98B
P/E ratio (TTM)123.28x17.03x
P/S ratio (TTM)7.07x5.28x
Dividend yield2.68%2.55%
Beta0.310.33
1-year return+36.87%+17.72%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.